64764-107 : Entyvio 108 mg/.68ml Subcutaneous Injection, Solution


NDC: 64764-107
Labeler: Takeda Pharmaceuticals America, Inc.
Product Type: Human Prescription Drug
Drug Name:  Entyvio
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA761133
Rev. Date: 


NDC Package Codes:

  • 64764-107-11: 1 TRAY IN 1 CARTON (64764‑107‑11) / 1 SYRINGE IN 1 TRAY (64764‑107‑10) / .68 ML IN 1 SYRINGE

Active Ingredients:

  • Vedolizumab

Dosage Strength:

  • 108 mg/.68mL

Pharmaceutical Classes:

  • Integrin Receptor Antagonist [EPC]
  • Integrin Receptor Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 64764-300 Entyvio 300 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Takeda Pharmaceuticals America, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 64764-107 QR Code

< Prev: 64764-105Next: 64764-108 >

Related Discussions:

Entyvio infusions
Anyone had success with Entyvio for Ulcerative Colitis? ## Hello, Jennifer! How are you? When do you start them? The FDA... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.